3.8. Change in Serum Biomarkers including the PTH and PTH/Ca Ratio by Osteo-F in Postmenopausal Women
ADVERSE EVENTS
As a result of comparing the change in OCN after 24 weeks, the change in OCN in the test group was increased (0.79 ± 3.02 ng/mL), and that in the control group was decreased (−0.10 ± 3.86 ng/mL) (In addition, the safety evaluation, including vital signs, e.g., blood pressure, temperature, and pulse, showed no significant changes, and no adverse events occurred in the subjects during the 24 weeks. 